Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|19 Sep 2013||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|21 Nov 2013||Reviewed||Reviewer Report - Chris Scarlett|
|1 Dec 2013||Reviewed||Reviewer Report - Adnan Nagrial|
|2 Jan 2014||Author responded||Author comments - Dirk Spitzer|
|Resubmission - Version 3|
|2 Jan 2014||Submitted||Manuscript version 3|
|18 Jan 2014||Editorially accepted|
|21 Jan 2014||Article published||10.1186/1471-2407-14-35|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.